APA (7th ed.) Citation

RC, K., K, B., MH, C., Y, S., S, C., BD, A., . . . PD, L. (2025). Multicenter Stroke Preclinical Assessment Network Analysis of Cardiovascular Risk Factor Subgroups Treated With the Poly(ADP-Ribose) Polymerase Inhibitor Veliparib. Journal of the American Heart Association, 14(19), e040914. https://doi.org/10.1161/JAHA.124.040914

Chicago Style (17th ed.) Citation

RC, Koehler, et al. "Multicenter Stroke Preclinical Assessment Network Analysis of Cardiovascular Risk Factor Subgroups Treated With the Poly(ADP-Ribose) Polymerase Inhibitor Veliparib." Journal of the American Heart Association 14, no. 19 (2025): e040914. https://doi.org/10.1161/JAHA.124.040914.

MLA (9th ed.) Citation

RC, Koehler, et al. "Multicenter Stroke Preclinical Assessment Network Analysis of Cardiovascular Risk Factor Subgroups Treated With the Poly(ADP-Ribose) Polymerase Inhibitor Veliparib." Journal of the American Heart Association, vol. 14, no. 19, 2025, p. e040914, https://doi.org/10.1161/JAHA.124.040914.